Discovery and engineering of colchicine alkaloid biosynthesis

Ryan S. Nett,Warren Lau,Elizabeth S. Sattely
DOI: https://doi.org/10.1038/s41586-020-2546-8
IF: 64.8
2020-07-22
Nature
Abstract:Few complete pathways have been established for the biosynthesis of medicinal compounds from plants. Accordingly, many plant-derived therapeutics are isolated directly from medicinal plants or plant cell culture<sup><a href="/articles/s41586-020-2546-8#ref-CR1">1</a></sup>. A lead example is colchicine, a US Food and Drug Administration (FDA)-approved treatment for inflammatory disorders that is sourced from <i>Colchicum</i> and <i>Gloriosa</i> species<sup><a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="#ref-CR4">4</a>,<a href="/articles/s41586-020-2546-8#ref-CR5">5</a></sup>. Here we use a combination of transcriptomics, metabolic logic and pathway reconstitution to elucidate a near-complete biosynthetic pathway to colchicine without prior knowledge of biosynthetic genes, a sequenced genome or genetic tools in the native host. We uncovered eight genes from <i>Gloriosa superba</i> for the biosynthesis of <i>N</i>-formyldemecolcine, a colchicine precursor that contains the characteristic tropolone ring and pharmacophore of colchicine<sup><a href="/articles/s41586-020-2546-8#ref-CR6">6</a></sup>. Notably, we identified a non-canonical cytochrome P450 that catalyses the remarkable ring expansion reaction that is required to produce the distinct carbon scaffold of colchicine. We further used the newly identified genes to engineer a biosynthetic pathway (comprising 16 enzymes in total) to <i>N</i>-formyldemecolcine in <i>Nicotiana benthamiana</i> starting from the amino acids phenylalanine and tyrosine. This study establishes a metabolic route to tropolone-containing colchicine alkaloids and provides insights into the unique chemistry that plants use to generate complex, bioactive metabolites from simple amino acids.
multidisciplinary sciences
What problem does this paper attempt to address?